257 related articles for article (PubMed ID: 9450507)
1. The activation of cannabinoid receptors in striatonigral GABAergic neurons inhibited GABA uptake.
Romero J; de Miguel R; Ramos JA; Fernández-Ruiz JJ
Life Sci; 1998; 62(4):351-63. PubMed ID: 9450507
[TBL] [Abstract][Full Text] [Related]
2. Perinatal delta9-tetrahydrocannabinol exposure augmented the magnitude of motor inhibition caused by GABA(B), but not GABA(A), receptor agonists in adult rats.
Garcia-Gil L; de Miguel R; Romero J; Perez A; Ramos JA; Fernández-Ruiz JJ
Neurotoxicol Teratol; 1999; 21(3):277-83. PubMed ID: 10386831
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoids inhibit striatonigral GABAergic neurotransmission in the mouse.
Wallmichrath I; Szabo B
Neuroscience; 2002; 113(3):671-82. PubMed ID: 12150787
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the effect of cannabinoids on GABAergic neurotransmission in the substantia nigra pars reticulata.
Wallmichrath I; Szabo B
Naunyn Schmiedebergs Arch Pharmacol; 2002 Apr; 365(4):326-34. PubMed ID: 11919658
[TBL] [Abstract][Full Text] [Related]
5. Effects of chronic exposure to delta9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions.
Romero J; Garcia-Palomero E; Castro JG; Garcia-Gil L; Ramos JA; Fernandez-Ruiz JJ
Brain Res Mol Brain Res; 1997 Jun; 46(1-2):100-8. PubMed ID: 9191083
[TBL] [Abstract][Full Text] [Related]
6. The novel antiepileptic drug levetiracetam (ucb L059) induces alterations in GABA metabolism and turnover in discrete areas of rat brain and reduces neuronal activity in substantia nigra pars reticulata.
Löscher W; Hönack D; Bloms-Funke P
Brain Res; 1996 Oct; 735(2):208-16. PubMed ID: 8911659
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoid receptor and WIN-55,212-2-stimulated [35S]GTP gamma S binding and cannabinoid receptor mRNA levels in the basal ganglia and the cerebellum of adult male rats chronically exposed to delta 9-tetrahydrocannabinol.
Romero J; Berrendero F; García-Gil L; Ramos JA; Fernández-Ruiz JJ
J Mol Neurosci; 1998 Oct; 11(2):109-19. PubMed ID: 10096037
[TBL] [Abstract][Full Text] [Related]
8. GABAergic afferents activate both GABAA and GABAB receptors in mouse substantia nigra dopaminergic neurons in vivo.
Brazhnik E; Shah F; Tepper JM
J Neurosci; 2008 Oct; 28(41):10386-98. PubMed ID: 18842898
[TBL] [Abstract][Full Text] [Related]
9. Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's disease.
Lastres-Becker I; Hansen HH; Berrendero F; De Miguel R; Pérez-Rosado A; Manzanares J; Ramos JA; Fernández-Ruiz J
Synapse; 2002 Apr; 44(1):23-35. PubMed ID: 11842443
[TBL] [Abstract][Full Text] [Related]
10. GABAergic nerve terminals decrease in the substantia nigra following hemitransections of the striatonigral and pallidonigral pathways.
Ribak CE; Vaughn JE; Roberts E
Brain Res; 1980 Jun; 192(2):413-20. PubMed ID: 7378797
[TBL] [Abstract][Full Text] [Related]
11. Serotonergic regulation of the GABAergic transmission in the rat basal ganglia.
Di Cara B; Samuel D; Salin P; Kerkerian-Le Goff L; Daszuta A
Synapse; 2003 Nov; 50(2):144-50. PubMed ID: 12923817
[TBL] [Abstract][Full Text] [Related]
12. Functional changes in rat nigral GABA(A) receptors induced by degeneration of the striatonigral GABAergic pathway: an electrophysiological study of receptors incorporated into Xenopus oocytes.
Sanna E; Motzo C; Usala M; Pau D; Cagetti E; Biggio G
J Neurochem; 1998 Jun; 70(6):2539-44. PubMed ID: 9603220
[TBL] [Abstract][Full Text] [Related]
13. Effects of BDNF and NT-4/5 on striatonigral neuropeptides or nigral GABA neurons in vivo.
Arenas E; Akerud P; Wong V; Boylan C; Persson H; Lindsay RM; Altar CA
Eur J Neurosci; 1996 Aug; 8(8):1707-17. PubMed ID: 8921261
[TBL] [Abstract][Full Text] [Related]
14. Effects of cannabinoids on prolactin and gonadotrophin secretion: involvement of changes in hypothalamic gamma-aminobutyric acid (GABA) inputs.
de Miguel R; Romero J; Muñoz RM; García-Gil L; González S; Villanua MA; Makriyannis A; Ramos JA; Fernández-Ruiz JJ
Biochem Pharmacol; 1998 Nov; 56(10):1331-8. PubMed ID: 9825732
[TBL] [Abstract][Full Text] [Related]
15. gamma-Aminobutyric acid function in the rat striatum is under the double influence of nigrostriatal dopaminergic and thalamostriatal inputs: two modes of regulation?
Samuel D; Kumar U; Nieoullon A
J Neurochem; 1988 Dec; 51(6):1704-10. PubMed ID: 3141584
[TBL] [Abstract][Full Text] [Related]
16. Subthalamic stimulation-induced synaptic responses in substantia nigra pars compacta dopaminergic neurons in vitro.
Iribe Y; Moore K; Pang KC; Tepper JM
J Neurophysiol; 1999 Aug; 82(2):925-33. PubMed ID: 10444687
[TBL] [Abstract][Full Text] [Related]
17. The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease.
Glass M; Dragunow M; Faull RL
Neuroscience; 2000; 97(3):505-19. PubMed ID: 10828533
[TBL] [Abstract][Full Text] [Related]
18. Distribution of GABAergic neurons in the striatum of amygdala-kindled rats: an immunohistochemical and in situ hybridization study.
Löscher W; Schirmer M; Freichel C; Gernert M
Brain Res; 2006 Apr; 1083(1):50-60. PubMed ID: 16545783
[TBL] [Abstract][Full Text] [Related]
19. GABAergic control of substantia nigra dopaminergic neurons.
Tepper JM; Lee CR
Prog Brain Res; 2007; 160():189-208. PubMed ID: 17499115
[TBL] [Abstract][Full Text] [Related]
20. In vivo release of [3H]GABA in cat caudate nucleus and substantia nigra. II. Involvement of different thalamic nuclei in the bilateral changes induced by a nigral application of muscimol.
Kemel ML; Gauchy C; Glowinski J; Besson MJ
Brain Res; 1984 Jun; 303(2):203-13. PubMed ID: 6331570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
